Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/2029660]Funding Amount $1,083,241.20
Full description Oral cancer has a poor prognosis. RNA-based therapies offer a new avenue of treatment for these patients. Herein, we will explore the ability of a small RNA called a microRNA to stop oral cancer in its tracks. Specifically, we have developed a microRNA called miR-7 that inhibits the growth of oral cancer cells in the lab and also overcomes resistance to chemotherapy. As a prerequisite for progression to an early phase clinical trial, we will evaluate this novel therapy in preclinical models.
Chief Investigator Prof Peter Leedman
Date Announced 2023-12-15T00:00:00
Sector University
Spatial Coverage And Location
text: WA
- nhmrc : 2029660
- PURL : https://purl.org/au-research/grants/nhmrc/2029660
